Blog

Jo Taylor: We Need Drug Developments to Overcome Access Inequality in the UK

mollisurgical.com/jo-taylor-2/

Nov 7, 2024, 07:14

Jo Taylor: We Need Drug Developments to Overcome Access Inequality in the UK

Jo Taylor, Founder of After Breast Cancer Diagnosis, posted the following on X:

“We need drug developments to get through the broken National Institute for Health and Care Excellence severity modifier system & available on NHS England because now we have an inequality in the UK where Scotland can access Enhertu for HER2low but England, Wales & Northern Ireland can’t…

Its a crazy situ that patients are in.

Shame on those who stopped this from being approved… I can only see that this will cause big problems for pharma in the future & we METUPUK worry for what will happen…

Awareness & mammograms wont help us – whats the point of a new drug if its not there to help patients survive? Where are the outcomes?”

access inequality cancer cancer care drug development England HER2low Jo Taylor NHS England NICEComms Northern Ireland OncoDaily Oncology Scotland Wales

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage